No Win for Milrinone Over Dobutamine in Cardiogenic Shock No Win for Milrinone Over Dobutamine in Cardiogenic Shock

Contrary to expectations, the long-awaited double-blind DOREMI trial was"another swing and a miss" for the field.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news